Tag Archives: FDA

Medical Cannabis – Myth, medicine, or malpractice?

By: Paul R. DeMuro, PhD and Dr. Jose Valdes, PharmD, BCPP Medical cannabis or cannabinoids (or medical marijuana as some like to call it) is now a reality in Florida.  Although it can only be recommended for certain maladies and … Continue reading

Posted in Malpractice, Paul DeMuro | Tagged , , , , , , , , ,

FDA extends comment period for Draft Social Media Regulations

By: Nichole Geary On June 18, 2014, the FDA released Draft Social Media Guidance for the marketing of medical devices and pharmaceuticals. The Draft Guidance addressed such issues as risk disclosure in light of the character limitations of social media … Continue reading

Posted in Regulatory | Tagged , , , , , , , , , , , , , , , , ,